Stewart Mostofsky is a Neurologist in Baltimore, Maryland. Dr. Mostofsky is rated as an Elite provider by MediFind in the treatment of Autism Spectrum Disorder. His top areas of expertise are Autism Spectrum Disorder, Apraxia, Tourette Syndrome, and Transient Tic Disorder.

Roma Vasa is a Psychiatrist and a Child and Adolescent Psychiatrist in Baltimore, Maryland. Dr. Vasa is rated as an Elite provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Obsessive-Compulsive Disorder (OCD), and Generalized Anxiety Disorder (GAD).

Andrew Feinberg studied mathematics and humanities at Yale in the Directed Studies honors program, and he received his B.A. (1973) and M.D. (1976) from the accelerated medical program at Johns Hopkins University, as well as an M.P.H. from Johns Hopkins (1981). He performed a postdoctoral fellowship in developmental biology at UCSD, clinical training in medicine at University of Pennsylvania, and genetics research and clinical training at Johns Hopkins. Dr. Feinberg is considered the founder of the field of cancer epigenetics, having discovered altered DNA methylation in cancer in the early 1980’s with Bert Vogelstein. Over the decades since, Feinberg and his colleagues have shaped the landscape of our understanding of DNA methylation and other epigenetic changes, and their applications to epidemiology and medicine, and have introduced groundbreaking statistical and laboratory methods to the study of the epigenome. He and his colleagues discovered human imprinted genes and loss of imprinting (LOI) in cancer, and they proved the epigenetic hypothesis of cancer through their work on Beckwith-Wiedemann syndrome. Most recently, they pioneered genome-scale epigenetics (epigenomics), with the first NIH funded Epigenome Center, pioneering methods including the first comprehensive genome-scale methylation discovering the major target for epigenetic variation in humans, CpG island shores. He led the first whole genome bisulfite sequencing analysis of human cancer, discovering large hypomethylated blocks that correspond to nuclear lamina-associated heterochromatin, as well as a mechanism for disruption of these blocks in epithelial-mesenchymal transition. He has also helped to create the field of epigenetic epidemiology, discovering epigenetic mediation of genetic variants in disease. He has made several important theoretical contributions as well, including the epigenetic progenitor hypothesis of cancer and the role of entropy in epigenetic development and disease. He is a Bloomberg Distinguished Professor in the Johns Hopkins University Schools of Medicine, Engineering and Public Health, where he is Director of the Center for Epigenetics. He is a recipient of an NIH Director’s Pioneer Award, is a member of the National Institute of Medicine, the American Academy of Arts and Science, the NIH Council of Councils, and he has received honorary doctorates from the University of Uppsala, the Karolinska Institute, and the University of Amsterdam. Feinberg Lab Website. Dr. Feinberg is rated as an Advanced provider by MediFind in the treatment of Autism Spectrum Disorder. His top areas of expertise are Autism Spectrum Disorder, Acute Myeloid Leukemia (AML), Leukemia, and Metabolic Syndrome.

Dr. López-Arvizu is a child and adolescent psychiatrist and the director of Outpatient Psychiatric Services at Kennedy Krieger Institute at the Center for Developmental Behavioral Health. Dr. López-Arvizu is also an assistant professor of Psychiatry and Behavioral Sciences at The Johns Hopkins School of Medicine, as well as a member of the faculty in the Department of Psychiatry at Johns Hopkins Hospital. Dr. López-Arvizu received her medical degree from the Instituto Tecnologico y de Estudios Superiores de Monterrey in 1995. She served as an intern in internal medicine at Texas Tech University Health Sciences Center, a resident in psychiatry at the University of Maryland/Sheppard Pratt Hospital, where she was chief resident where she got the Award for Clinical Excellence as a resident. She then completed her child and adolescent psychiatry fellowship at Johns Hopkins University School of Medicine where she spent time at Kennedy Krieger Institute as part of her training to later stay on as faculty. As a clinician, Dr. López-Arvizu treats individuals with psychiatric illness in the context of Neurodevelopmental disorders where she has developed an expertise in psychopharmacological management of children with developmental disabilities and severe behavioral presentations by developing a collaboration with the other disciplines involved in their care. She has been recognized as a Top Doctor by Baltimore Magazine. She has also been recognized by her peers by being awarded the Arabella Leet Award in Clinical Excellence at Kennedy Krieger. As an educator, teaching physicians-in-training is a priority and a personal mission. Future child psychiatrists learn how to evaluate and treat the dually diagnosed child and the complex-care patients which are the Kennedy Krieger Institute specialty. Her clinical, education and program development effortsare always focused on improving the psychiatric diagnosis and treatment outcome of children and adolescents with complex and severe Neurodevelopmental disorders. Advocating for and improving services for families caring for a child, adolescent, or adult with neurodevelopmental and psychiatric disorders—through education directed at policymakers, the public (including schools and parents), and medical professionals—while addressing barriers to accessing systems of care by developing services not available in the community. Dr. Lopez is rated as an Advanced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Autism Spectrum Disorder, Obsessive-Compulsive Disorder (OCD), Generalized Anxiety Disorder (GAD), and Tourette Syndrome.

Dr. Chana Richter is a pediatrician at the Kennedy Krieger Institute, with a focus in developmental disabilities. She works at the Center for Autism and Related Disorders, primarily focusing on new diagnosis of Autism Spectrum Disorders. Dr. Richter received her Bachelors in Science from Touro University/Lander College of Arts and Sciences, and completed her Masters in Education and Special Education through Touro as well. She taught children of varying ages and abilities, and was the Assistant Director of a school for children with special needs for several years. Dr. Richter studied medicine at the Sackler School of Medicine at Tel Aviv University. She completed residency in Pediatrics at the Johns Hopkins Hospital and focused training in the diagnosis and care of children with autism at the Kennedy Krieger Institute. Her current focus is bridging the gap to diagnosis of autism and initiation of supportive treatment, as well identifying barriers to diagnosis. Dr. Richter is rated as a Distinguished provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Autism Spectrum Disorder, Delayed Growth, and Developmental Dysphasia Familial.

Arif Mannan is a Pediatrics provider in Glen Burnie, Maryland. Dr. Mannan is rated as an Advanced provider by MediFind in the treatment of Autism Spectrum Disorder. His top areas of expertise are Multisystem Inflammatory Syndrome in Children (MIS-C), Respiratory Syncytial Virus (RSV) Infection, Viral Gastroenteritis, and Croup. Dr. Mannan is currently accepting new patients.

Christina Morris is a Pediatric Neurologist in Baltimore, Maryland. Dr. Morris is rated as an Advanced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Autism Spectrum Disorder, Stereotypic Movement Disorder, Spasmus Nutans, and Aphantasia.

Dr. Hilary Vernon is a Professor of Genetic Medicine and pediatrics at the Johns Hopkins University School of Medicine. She is also an attending physician at Kennedy Krieger Institute. Hilary Vernon has expertise in treating inborn errors of metabolism and mitochondrial disorders. She is the director of the Mitochondrial Care Center at The Johns Hopkins Hospital and the Barth Syndrome Interdisciplinary Clinic at the Kennedy Krieger Institute. Her research interests include understanding intermediary metabolism in Barth syndrome and in disorders of branch chain amino acid metabolism. Dr. Vernon also co-directs the Department of Genetic Medicine Clinical Trials Unit, and is the principal investigator on multiple clinical trials for rare diseases. Dr. Vernon received her medical degree and doctorate from Rutgers University, New Brunswick, New Jersey. She completed residencies in genetics and pediatrics at The Johns Hopkins University, and a fellowship in clinical laboratory biochemical genetics at The Johns Hopkins University. Dr. Vernon was recognized with the 2010 Francis F. Schwentker Award for Excellence in Research at Johns Hopkins University and the 2011 James B. Sidbury Jr. Fellowship in Biochemical Genetics at Johns Hopkins University. Dr. Vernon is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Methylmalonic Acidemia, Propionic Acidemia, Infantile Neutropenia, Progressive External Ophthalmoplegia, and Gastrostomy.

Dr. Barañano earned her M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine, where she also completed residencies in pediatrics and neurology, along with a fellowship in neurogenetics at the Kennedy Krieger Institute. Dr. Barañano is an Associate Professor of Clinical Neurology. She specializes in the diagnosis and management of rare neurogenetic disorders. She has a particular interest in the genetic control and function of the cerebellum and expertise in childhood-onset and inherited ataxias. She is a member of the multidisciplinary Fetal Management group and is available for prenatal consultations. Dr. Barañano's research includes collaborative efforts with the Johns Hopkins Department of Genetic Medicine and the Division of Neurogenetics at the Kennedy Krieger Institute. Dr. Baranano is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Hypotonia, Ohdo Syndrome, Say-Barber-Biesecker-Young-Simpson Variant, Focal or Multifocal Malformations in Neuronal Migration, and Hereditary Ataxia.

Dr. Ada Hamosh is the Dr. Frank V. Sutland Professor of Pediatric Genetics in the Departments of Genetic Medicine and Pediatrics. Since 2002, she has served as clinical director of the McKusick-Nathans Institute of Genetic Medicine, now Department of Genetic Medicine and scientific director of the Online Mendelian Inheritance in Man® (OMIM), a catalog of more than 16,800 human genes and genetic disorders created by Dr. Victor A. McKusick. Her research centers the molecular basis of Mendelian disorders, the integration of genetics into clinical practice and the diagnosis and management of inborn errors of metabolism. Dr. Hamosh earned a bachelor’s degree in biology from Wesleyan University, a medical degree from Georgetown University School of Medicine and a master’s of public health from Johns Hopkins University School of Public Health. She later completed a fellowship in medical and biochemical genetics from the Johns Hopkins School of Medicine, before joining the Johns Hopkins faculty in 1992. Dr. Hamosh began her genetics career focusing on cystic fibrosis, serving as coordinator of the International Cystic Fibrosis Genotype-Phenotype Consortium. She served as chair of the Maryland State Advisory Council for Hereditary & Congenital Disorders from 2001-2009, during which time she also served on the executive committee of the Genetic Counseling Training Program, run by Johns Hopkins University and the National Human Genome Research Institute. Dr. Hamosh has authored more than 128 publications on a variety of topics. In addition, she is a member of 16 professional associations and advisory committees including the American Society of Human Genetics, the Steering Committee of the Global Alliance for Genomics and Health, and the executive board of the Human Genome Organization, of which she will be President from 2023-2025. Dr. Hamosh was recognized in Baltimore magazine as one of the region’s top doctors in 2013, and 2016-2020. Dr. Hamosh is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Methylmalonic Acidemia, Maple Syrup Urine Disease, Ornithine Transcarbamylase Deficiency, Phenylketonuria (PKU), and Deep Brain Stimulation.

Dr. Stephanie Green completed her Masters at Tulane University in Cell and Molecular Biology, prior to completing her medical degree at Louisiana State University Health. She then completed her residency in pediatrics at the Johns Hopkins Hospital. She completed a fellowship in pediatric endocrinology at the Children's Hospital of Philadelphia. She received additional training in obesity medicine through Columbia University. Dr. Green has been a faculty member in the Division of Pediatric Endocrinology at Johns Hopkins Children's Center and the Kennedy Krieger Institute since 2022. Dr. Green specializes in providing care to children with elevated weight and metabolic syndrome conditions at both Kennedy Krieger and Johns Hopkins Children's Center. Her clinical activities include directing of the Fit and Healthy Kids Multidisciplinary Clinic at Kennedy Krieger Institute, a clinic designed to treat elevated weight in children with physical or cognitive differences and disabilities. Additionally, she designed and directed the bi-weekly Healthy Families Program at Johns Hopkins Children's Center, a biweekly lifestyle medicine group designed to help the whole family achieve better health. Dr. Green additionally sees children with diabetes as a part of a multidisciplinary team consisting of certified diabetes educators, registered dietitians, and a team of psychologists with extensive training and expertise in the unique issues surrounding the management of diabetes in children. She also has general pediatric endocrine clinics in which she evaluates and treats a variety of disorders including short stature, abnormal pubertal development, thyroid disorders, polycystic ovary syndrome, hypopituitarism, diabetes insipidus, pituitary adenoma, congenital adrenal hyperplasia and disorders of sexual differentiation, Turner syndrome and Prader Willi syndrome among others. Dr. Green is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Autism Spectrum Disorder and Obesity.

Dr. Nathan Crone focuses on the diagnosis and treatment of seizures and epilepsy, including the surgical treatment of epilepsy. He is also one of the attending physicians in the Epilepsy monitoring unit. Dr. Crone''s research interests include the real-time mapping of brain function to reduce the possibility of impacting brain function during surgery for epilepsy. He received his medical degree from Louisiana State University School of Medicine. He then completed his residency in neurology at the University of Chicago and fellowships in epilepsy and cognitive neurology at Johns Hopkins. Dr. Crone is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. His top areas of expertise are Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Deep Brain Stimulation.

Dr. Julie Hoover-Fong is a Professor of Genetic Medicine and Pediatrics and Director of the Greenberg Center for Skeletal Dysplasias at Johns Hopkins University. Dr. Hoover-Fong holds a bachelor’s degree in Human Nutrition from The Ohio State University, where she also completed her medical degree. She received her Ph.D. in the Graduate Training Program in Clinical Investigation at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Hoover-Fong completed a pediatric internship and residency at Washington University in St. Louis and a fellowship in medical genetics at Johns Hopkins University in Baltimore. She joined the Johns Hopkins University faculty in 2002 and progressed to Professor of Genetic Medicine and Pediatrics in 2019. She practices and oversees the clinical operations, research and educational ventures for the patients, families and healthcare providers served by the Greenberg Center. Her clinical team develops and improves diagnostic and treatment guidelines for comprehensive care of patients with all types of bone conditions including dwarfism, orofacial clefting, craniosynostosis and more. Dr. Hoover-Fong also mentors and teaches medical students, residents and genetic medicine trainees. As an active clinical researcher, Dr. Hoover-Fong is the Principal Investigator of multiple global clinical trials for achondroplasia, the first multi-center, investigator-initiated natural history study for achondroplasia, and multiple clinical studies for patients with orofacial clefting, hypophosphatasia and other conditions. She is also a co-investigator on the ELSI and Phenotype Review Committees for the Mendel Project, a whole exome sequencing venture to identify the genetic cause of Mendelian conditions. From an institutional service perspective, Dr. Hoover-Fong serves on the Johns Hopkins Associate Professor Promotions Committee and the Advisory Committee for the Graduate Training Program in Clinical Investigation. She serves on the Medical Advisory Board of the Little People of America, is a member of the Miller-Coulson Academy of Clinical Excellence at Johns Hopkins University and is a charter member of the International Skeletal Dysplasia Management Consortium, publishing best practice guidelines for patients with skeletal dysplasias. Dr. Hoover is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Achondroplasia, Rhizomelic Syndrome, Spondyloepimetaphyseal Dysplasia Strudwick Type, Adenoidectomy, and Myringotomy.

Catherine Chu is the director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center in the Johns Hopkins Department of Neurology, as well as the vice president of child neurology at the Kennedy Krieger Institute. As a child neurologist, epileptologist and clinical neurophysiologist, Dr. Chu cares for children diagnosed with epilepsy and disorders of the nervous system (neurophysiology). She specializes in electroencephalogram (also known as EEG) analysis, seizure localization, surgical planning and neuromodulation for adult and pediatric patients with difficult to control epilepsy. She is nationally and internationally recognized for her work identifying causes of and treatment options for cognitive dysfunction and seizures in epilepsy and neurodevelopmental disorders. Dr. Chu’s team specializes in identifying and developing tools to detect and understand brain rhythms that support complex cognitive functions throughout development, including how these rhythms are disrupted by seizures and neurodevelopmental disorders. Dr. Chu earned her medical degree and a master’s degree in social anthropology from Harvard University. She completed an internship in pediatrics at Massachusetts General Hospital, and then a residency in neurology and child neurology at Massachusetts General and Brigham and Women’s Hospital. After completing two fellowships at Massachusetts General, one in epilepsy and another in clinical neurophysiology, Dr. Chu earned a master’s degree in medical science, focused on clinical investigation, from Harvard Medical School. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Benign Rolandic Epilepsy, Epilepsy in Children, Seizures, and Epilepsy.

Ambroise Wonkam is a Pediatrics specialist and a Medical Genetics provider in Baltimore, Maryland. Dr. Wonkam is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. His top areas of expertise are Anemia, Fragile X Syndrome, Pyle Disease, and Micrognathia.

Carl E. Stafstrom is a pediatric neurologist, caring for children with epilepsy. Dr. Stafstrom received his medical degree from the University of Washington School of Medicine in Seattle, with residencies at the University of Washington Medical Center and Tufts New England Medical Center, as well as fellowships at Harvard for neurology research and Boston Children’s Hospital in clinical neurophysiology, electroencephalography, and epilepsy. Dr. Stafstrom previously served as Professor of Neurology and Pediatrics at the University of Wisconsin-Madison School of Medicine and Public Health and Chief of Pediatric Neurology at American Family Children’s Hospital at UW Madison. Dr. Stafstrom is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. His top areas of expertise are Epilepsy, Seizures, West Syndrome, Endovascular Embolization, and Deep Brain Stimulation.

"O. Joseph (""Joe"") Bienvenu, M.D., Ph.D. is the Judy Yin Shih, PhD Professor in Anxiety Disorders at Johns Hopkins. He completed his psychiatric training at Johns Hopkins in 1996, having served as chief resident in his final year. Dr. Bienvenu joined the faculty full-time in 1999 after completing a research fellowship in psychiatric epidemiology and a doctorate through the Johns Hopkins Graduate Training Program in Clinical Investigation. His current area of particular research interest is psychiatric morbidity in critical illness survivors, particularly posttraumatic stress disorder and related conditions. Dr. Bienvenu directs the academic program for resident education in anxiety disorders, which includes the John and Mary McGlasson Anxiety Disorders Clinic, as well as the psychiatric Residents' Outpatient Continuity Clinic, and the inpatient Consultation-Liaison services at Johns Hopkins Hospital.". Dr. Bienvenu is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. His top areas of expertise are Obsessive-Compulsive Disorder (OCD), Post-Traumatic Stress Disorder (PTSD), Delirium, and Major Depression.

Dr. Sara Mixter is Assistant Professor of Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her areas of clinical expertise are internal medicine, pediatrics, and primary care for adults with developmental disabilities and other complex childhood-onset conditions. She is the director of the Hopkins PACT (Pediatric-informed Adult Care and Transition) Clinic. Dr. Mixter is also the medical director of the Pediatric Complex Care Collaborative (PC3) for the Johns Hopkins Children’s Center. Dr. Mixter received her A.B. from Harvard College. She earned her M.D. from Harvard Medical School and M.P.H. from the Harvard School of Public Health. She completed her residency at Johns Hopkins as part of the inaugural group of trainees in the Urban Health Combined Internal Medicine-Pediatrics Residency Program. Her research interests include transitions of care for adolescents with special healthcare needs and education for residents and medical students, especially in primary care and complex care. Dr. Mixter has served as the Assistant Chief of Service for the Longcope firm of the Osler Medical Housestaff Training Program (2015-16), as well as Assistant Program Director for Ambulatory Education (2014-15). Dr. Mixter is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Cerebral Palsy, Gastroparesis, Orbital Cellulitis, and Sickle Cell Disease.

Dr. Jill A. Fahrner is an assistant professor in the Departments of Genetic Medicine and Pediatrics at the Johns Hopkins University School of Medicine. Her area of clinical expertise is medical genetics. Dr. Fahrner earned her Ph.D. from Johns Hopkins University and her M.D. from the University of North Carolina. She completed pediatrics residency training at Duke University Medical Center. She joined the McKusick-Nathans Institute of Genetic Medicine as a genetic medicine resident in 2009 and completed her training in 2012. She stayed on as chief resident from 2012-2013 and then joined the faculty as an assistant professor in the Department of Pediatrics within the McKusick-Nathans Institute of Genetic Medicine in 2013. Her current primary appointment is Assistant Professor in the Department of Genetic Medicine, where she is Director of the multidisciplinary Epigenetics and Chromatin Clinic. She is a physician-scientist with a long-standing interest in epigenetic mechanisms of disease. Her clinical focus is on caring for individuals with epigenetic and chromatin disorders, specifically Mendelian disorders of the epigenetic machinery, or chromatin modifying disorders. She has seen hundreds of individuals with congenital disorders involving disrupted epigenetics, most of which exhibit neurodevelopmental disabilities and abnormal growth. Her laboratory research is focused on understanding disease mechanisms and developing therapies for select Mendelian disorders of the epigenetic machinery. She is a member of the American Society of Human Genetics (ASHG), having won an ASHG Reviewer’s Choice Abstract Award for her work on growth retardation in Kabuki syndrome 1. She has received a Johns Hopkins School of Medicine Clinician Scientist Award, a Johns Hopkins School of Medicine Musculoskeletal Pilot and Feasibility Award, a William and Ella Owens Medical Research Foundation Award, the Margaret Ellen Nielsen Fellowship Award, and the Alice and YT Chen Travel Award while at Johns Hopkins. She is the recipient of a prestigious Hartwell Foundation Individual Biomedical Research Award and also has ongoing research funding from the National Institutes of Health. Dr. Fahrner is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. Her top areas of expertise are Weaver Syndrome, Sotos Syndrome, Kabuki Syndrome, and Marshall-Smith Syndrome.

Dr. Gerald Raymond is a clinical geneticist and neurologist at Johns Hopkins where he is also a professor of genetic medicine and neurology. He obtained his MD at the University of Connecticut and was trained in Pediatrics at Johns Hopkins Hospital and Neurology at the Mass. General Hospital. He received additional training in developmental neuropathology at the Universite Catholique de Louvain in Belgium and clinical genetics at the Harvard Program. Dr. Raymond’s research has been at the overlap of genetics and neurology with specific focus on peroxisomal disorders including adrenoleukodystrophy. He has been actively involved in newborn screening for ALD and in developing clinical follow-up programs. He has extensive experience in clinical management of neurogenetic issues including peroxisomal and lysosomal disorders. He presently serves as the Director of the Lysosomal Storage Disease program in the department of Genetic Medicine. Dr. Raymond is rated as an Experienced provider by MediFind in the treatment of Autism Spectrum Disorder. His top areas of expertise are Adrenoleukodystrophy (ALD), CACH Syndrome, Zellweger Syndrome, and Leukodystrophy.